Cancer.Net   
 Journal of Clinical Oncology   
 Journal of Oncology Practice   
 ASCO News & Forum   
 The ASCO Cancer Foundation   
 ASCO Press Center   
 

Home > Quality Care & Guidelines > Practice Guidelines > Guideline Clinical Tools and Resources > Supportive Care and Quality of Life


Clinical Tools and Resources for Supportive Care and Quality of Life



The purpose of these derivative products is to more widely disseminate, in a practical and user-friendly form, the recommendations contained in the guidelines. In the supportive care and quality of life area, ASCO currently has clinical tools and resources for four guidelines.

Clinical Tools and Tables

Chemotherapy and Radiation Therapy Protectants Update Table

Prophylaxis Algorithm for VTE and Treatment Algorithm for Recurrent VTE

VTE Prophylaxis Orders and Flow Sheet

Erythropoiesis Stimulating Agents (ESAs) Algorithm

Erythropoetin and Darbepoetin 2007 Update Revisions Table

Erythropoiesis Stimulating Agents (ESAs) Order and Flow Sheet

Antiemetics Drug, Dose, and Schedule Flow Sheet

Antiemetics 2006 Update Revisions Table

White Blood Cell Growth Factors Flow Sheet


Guideline Summaries

Erythropoiesis-Stimulating Agents  (ESAs) Guideline Summary

VTE Prophylaxis Guideline Summary

Antiemetics Guideline Summary

White Blood Cell Growth Factors Guideline Summary


Summary Slide Sets


Chemotherapy and Radiation Therapy Protectants Slide Set (ppt)

Chemotherapy and Radiation Therapy Protectants Slide Set (pdf)

VTE Prophylaxis Slide Set (ppt)

VTE Prophylaxis Slide Set (pdf)

Erthyropoiesis Stimulating Agents (ESAs) Slide Set (ppt)

Erthyropoiesis Stimulating Agents (ESAs) Slide Set (pdf)

Antiemetics Slide Set (ppt)

Antiemetics Slide Set (pdf)

White Blood Cell Growth Factors Slide Set (ppt)

White Blood Cell Growth Factors Slide Set (pdf)


Patient Guides

VTE Prophylaxis Patient Guide

Erthyropoiesis Stimulating Agents (ESAs) Patient Guide

Antiemetics Patient Guide

White Blood Cell Growth Factor Patient Guide



ASCO’s practice guidelines and technology assessments reflect expert consensus based on clinical evidence and literature available at the time they are written, and are intended to assist physicians in clinical decision-making and identify questions and settings for further research.  Due to the rapid flow of scientific information in oncology, new evidence may have emerged since the time a guideline or assessment was submitted for publication.  Guidelines and assessments are not continually updated and may not reflect the most recent evidence.  Guidelines and assessments cannot account for individual variation among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments.  It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine the best course of treatment for the patient.  Accordingly, adherence to any guideline or assessment is voluntary, with the ultimate determination regarding its application to be made by the physician in light of each patient's individual circumstances.  ASCO guidelines and assessments describe the use of procedures and therapies in clinical practice and cannot be assumed to apply to the use of these interventions in the context of clinical trials. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this guideline, or to any errors or omissions.
 



Related Links